EZH2 and cancer: These strains are associated with the induction of pro-oncogenic signatures, development of polyploid giant cancer cells (PGCCs), overexpression of enhancer of zeste homologue 2 (EZH2), and enhanced epithelial-to-mesenchymal (EMT) plasticity [13,16,32].